Dr. Louis Weiner, MD

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Tufts-new England Medical Center

  Fellowship Hospital, 1982

• Medical Center Hospital Of Vermont

  Residency Hospital, 1981

• Icahn School Of Medicine At Mount Sinai

  Medical School, 1977

• University Of Pennsylvania

  Undergraduate School, 1973

• English

• German

• Protein Network Construction Using Reverse Phase Protein Array Data, 2017-06-24

• T-Cell Immunity in Pancreatic Cancer, 2020-06-23

• CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer, 2019-04-19

• G-DOCPlus- an integrative bioinformatics platform for precision medicine, 2016-04-30

• RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack, 2019-07-03

• Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors, 2011-03-15

• Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer, 2016-07-06

• RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells, 2017-08-05

• Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis, 2018-04-09

• Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production, 2012-10-17

• Acquisition of Estrogen Independence Induces TOB1-Related Mechanisms Supporting Breast Cancer Cell Proliferation, 2015-07-13

• The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research, 2009-09-01

• Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice, 2017-10-17

• Translational Research Working Group Developmental Pathway for Immune Response Modifiers, 2008-09-15

• Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs, 2014-01-06

• Monoclonal Antibodies for Cancer Immunotherapy, 2009-03-21

• A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer, 2020-07-15